SOD1 and myalgic encephalomeyelitis/chronic fatigue syndrome: In a study on the mechanism of ginsenoside acid polysaccharide WGPA in the prevention of chronic fatigue syndrome (CFS), it was found that oral administration of WGPA for 15 days in mice could increase serum SOD and GSH-Px, improve mitochondrial structural degeneration, and prolong forced swimming time (81).